CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Olanzapine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00050206
NCT00050206Phase 4Completed
CompareCT.gov

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

Eli Lilly and Company·interventional·Posted Nov 27, 2002·Updated Jun 12, 2007

In Brief

A Phase 4 clinical trial evaluating Olanzapine and Placebo for Bipolar Disorder. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine the efficacy (how well the drug works), safety, and any side effects of olanzapine compared to placebo in the treatment of mania in bipolar disorder in adolescents. Both the potential benefits and side effects of olanzapine will be evaluated throughout this trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 27, 2002
Enrollment StartNov 1, 2002
Study CompletionMay 1, 2005
TodayJul 2, 2026
Posted 23.6 years ago

Interventions

Olanzapinedrug

Placebodrug